established companies focusing in the biotechnology and life science areas. Kenson Ventures also considers and participates in co-investment with other institutions. The range of investment varies from $500,000 to $3 million U.S. dollars. Since Kenson funds are often accompanied by co-investments from affiliated institutions, the actual amount of investment could be much greater than that provided by us. Majority of the investment are made in private companies in the United States. A Kenson Ventures representative normally serves on the board (member of the Board or Business Advisory Board) in which it has a vested interest.

We, at Kenson Ventures, understand the challenges of building a successful company. Our team is dedicated in assisting companies with strong growth potential. Our strength is in our knowledge base and industry experiences in building biotechnology companies in the past. When we make an investment, we do our best to provide growth strategy, resources and the contact network to assure success of the company.

Kenson Ventures consistently strives to make fruitful investment work. Our primary focus is on emerging-growth companies. We may also make investments in late-stage companies. In the short time since Kenson Ventures' inception, we have been involved in and financed over 20 rapidly growing companies representing a broad spectrum of technology platforms. The engagement of these companies ranges from the development of novel drugs, discovery of genomics-based drug targets and leads, to the development of research tools in molecular and cellular biology. For a listing of our previous and current investments, please visit our Portfolio Companies section.